VASTY KUM: Open Payments
NPI 1750055703 · UNION, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,075 in 135 payments from 13 companies in 2025. Trend: 2023 $967 · 2024 $822 · 2025 $2,075
Food & beverage: $2,075
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 70 | $788 |
| Janssen Pharmaceuticals, Inc | 15 | $275 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $252 |
| E.R. Squibb & Sons, L.L.C. | 5 | $198 |
| Otsuka America Pharmaceutical, Inc. | 15 | $168 |
| Neurocrine BioSciences, Inc. | 7 | $153 |
| Vanda Pharmaceuticals Inc. | 6 | $100 |
| Alkermes, Inc. | 3 | $57 |
| Indivior Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, COBENFY, SPRAVATO, INGREZZA, REXULTI, INVEGA SUSTENNA, FANAPT.
Industry payments across NJ — which companies pay providers there.
